Company intelligence / Profile preview

4D Pharma plc

Ownership: Private
Employees: ~106
Development stage: Phase 2

Overview

The company was developing MRx-4DP0004 in an ongoing Phase I/II trial for partly controlled asthma. The company is currently in administration (UK equivalent of bankruptcy).

Therapeutic areas: GastroenterologyPulmonologyImmunologyOncologyNeurology
Modalities: Live Biotherapeutic Products (LBPs)
Industry: Biotech

Drug pipeline

6 assets

MRx0518

5 more assets in the full pipeline.

Request access →

Partnerships

University of NottinghamUniversity of Edinburgh

Beyond the preview

Go deeper on 4D Pharma plc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4D Pharma plc.

Explore the full profile